Nuzenio

Leads Biolabs Announces

Leads Biolabs Announces news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 5 latest news signals 3 publisher sources 100/100 entity strength

Latest news

Nanjing Leads Biolabs Co., Ltd. (9887.HK) stock price, news, quote and history - Yahoo Finance SingaporeYahoo Finance Singapore · Fri, 07 Aug 2026 06:34:16 GMTLeads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Phase in First-Line Hepatocellular Carcinoma Following Positive Efficacy Signals - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 01:13:02 GMTOblenio Doses First Patients in Phase 1a Trial of Trispecific T-Cell Engager LBL-051 - BioPharm InternationalBioPharm International · Tue, 04 Aug 2026 17:05:26 GMTLeads Biolabs Announces Partner Oblenio Bio Doses First Patients in Phase 1a Trial of LBL‑051 for Refractory Autoimmune Diseases - The Manila TimesThe Manila Times · Tue, 04 Aug 2026 12:18:05 GMTLeads Biolabs' PD-L1/4-1BB Bispecific Antibody IND Application for Combination Therapy in Metastatic Colorectal Cancer Approved, Further Strengthening Gastrointestinal Oncology Franchise - The Manila TimesThe Manila Times · Mon, 03 Aug 2026 03:56:06 GMTLeads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Completes Patient Enrollment in Phase II Study for Biliary Tract Cancer, Further Demonstrating Breakthrough Potential in Immune-Cold Tumors - The Manila TimesThe Manila Times · Thu, 30 Jul 2026 10:40:18 GMT

Timeline

Fri, 07 Aug 2026 06:34:16 GMTNanjing Leads Biolabs Co., Ltd. (9887.HK) stock price, news, quote and history - Yahoo Finance Singapore
Thu, 06 Aug 2026 01:13:02 GMTLeads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Phase in First-Line Hepatocellular Carcinoma Following Positive Efficacy Signals - The Manila Times
Tue, 04 Aug 2026 17:05:26 GMTOblenio Doses First Patients in Phase 1a Trial of Trispecific T-Cell Engager LBL-051 - BioPharm International
Tue, 04 Aug 2026 12:18:05 GMTLeads Biolabs Announces Partner Oblenio Bio Doses First Patients in Phase 1a Trial of LBL‑051 for Refractory Autoimmune Diseases - The Manila Times
Mon, 03 Aug 2026 03:56:06 GMTLeads Biolabs' PD-L1/4-1BB Bispecific Antibody IND Application for Combination Therapy in Metastatic Colorectal Cancer Approved, Further Strengthening Gastrointestinal Oncology Franchise - The Manila Times
Thu, 30 Jul 2026 10:40:18 GMTLeads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Completes Patient Enrollment in Phase II Study for Biliary Tract Cancer, Further Demonstrating Breakthrough Potential in Immune-Cold Tumors - The Manila Times

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Leads Biolabs Announces.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.